Boston, Massachusetts – Wolf & Company has announced the acquisition of The Kafafian Group, Inc (https://kafafiangroup.com/). According to the company announcement Wolf & Company, P.C. is a nationally recognized accounting and consulting firm with 115…
Wellesley, Massachusetts – Allied Services Group has announced the acquisition of Substations, Inc (https://substations-inc.net/). According to the company announcement Allied Services Group, a platform company of investment firm Bear Castle Capital, stands as a market-leading…
At a $1.8 billion valuation, backed by L2 Point and Pure Storage, the company scales AI-first cloud storage to meet the explosive demands of modern data BOSTON, Mass.–(BUSINESS WIRE)–Wasabi Technologies, the Hot Cloud Storage company, today…
Boston, Massachusetts – Zelis has announced the acquisition of Rivet (https://www.rivethealth.com/). According to the company announcement Zelis is a prominent provider of healthcare technology solutions, dedicated to modernizing the financial experience for payers, providers, and…
Boston, Massachusetts – OneSpan has announced the acquisition of Build38 (https://build38.com/). According to the company announcement, OneSpan Inc. (NASDAQ: OSPN) is a global provider of secure authentication, identity, electronic signature, and digital workflow solutions, designed…
Led by Mitsubishi Electric, the investment brings the company’s valuation to $1.3B, and will accelerate the end of rigid industrial software BOSTON–(BUSINESS WIRE)–Tulip, the leading frontline operations platform, announced today that Mitsubishi Electric Corporation (TOKYO: 6503) has…
Series B Co-led by New Investors Amplitude Ventures and ICG MTX-474 Global Phase 2a study Initiated in Systemic Sclerosis (SSc) MTX-463 Global Phase 2a Study in Idiopathic Pulmonary Fibrosis (IPF) Enrolling & Partnered with Lilly…
– Financing co-led by Forbion and Population Health Partners – – Dosing initiated in Phase 1 clinical trial of COR-1004, a novel PCSK9 siRNA – BOSTON–(BUSINESS WIRE)–Corsera Health, Inc., a clinical-stage company leading the future of…
Phase 1 clinical trial underway for PHB-050, a next-generation IgE depleter, with data expected in 2H26 Series A financing led by SR One, Vida Ventures, and Platanus Poplar to present at the 44th Annual J.P….
Financing round led by RA Capital Management and Forge Life Science Partners, with contributions from new and existing investors Proceeds to advance frevecitinib, an inhaled pan-JAK inhibitor with the potential to treat the broad severe…